A previous clinical trial found that tamoxifen, taken for five years, reduced the risk of developing invasive breast cancer by about 50% in post-menopausal women who were at increased risk of getting the disease.
Another trial found that five years of raloxifene reduces breast cancer risk in such women by about 38%.
Under the new plans, high risk post-menopausal women could be offered the drugs for a period of five years unless they have a history of thromboembolic disease or endometrial cancer.
More top news
The actor joined hundreds of mourners at the funeral of the 30-year-old make up artist in the village of Cappawhite, Ireland.
Odense zoo plans to publicly dissect a year-old lion - undeterred by outrage at giraffe who was killed in Copenhagen last year.
The Duke and Duchess of Cambridge met young people who have battled mental health issues on Saturday.